Suppression of amygdaloid kindled convulsion following bilateral injection of 2-amino-7-phosphonoheptanoic acid into the substantia nigra of rats.
Mori
N
N
Department of Neuropsychiatry, Fukushima Medical College.
Shimoyamada
K
K
Kumashiro
H
H
D015763:2-Amino-5-phosphonovalerate / Q000031:analogs & derivatives*; D000596:Amino Acids / Q000494:pharmacology*; D000679:Amygdala / Q000187:drug effects*; D000818:Animals; D000927:Anticonvulsants; D004292:Dominance, Cerebral / Q000187:drug effects*; D004569:Electroencephalography / Q000187:drug effects; D005071:Evoked Potentials / Q000187:drug effects; D007267:Injections; D007696:Kindling, Neurologic / Q000187:drug effects*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D013378:Substantia Nigra / Q000187:drug effects*
D000596:Amino Acids; D000927:Anticonvulsants; D016194:Receptors, N-Methyl-D-Aspartate; D015763:2-Amino-5-phosphonovalerate; C031231:2-amino-7-phosphonoheptanoic acid